Erste Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Hold |
|
|||||
|
2025
Q1 | $463K | Hold |
|
|||||
|
2024
Q4 | $470K | Hold |
|
|||||
|
2024
Q3 | $419K | Hold |
|
|||||
|
2024
Q2 | $354K | Hold |
|
|||||
|
2024
Q1 | $306K | Hold |
|
|||||
|
2023
Q4 | $309K | Hold |
|
|||||
|
2023
Q3 | $264K | Hold |
|
|||||
|
2023
Q2 | $312K | Hold |
|
|||||
|
2023
Q1 | $307K | Hold |
|
|||||
|
2022
Q4 | $291K | Sell |
|
|||||
|
2022
Q3 | $368K | Hold |
|
|||||
|
2022
Q2 | $380K | Hold |
|
|||||
|
2022
Q1 | $500K | Hold |
|
|||||
|
2021
Q4 | $700K | Hold |
|
|||||
|
2021
Q3 | $602K | Hold |
|
|||||
|
2021
Q2 | $581K | Hold |
|
|||||
|
2021
Q1 | $641K | Hold |
|
|||||
|
2020
Q4 | $425K | Sell |
|
|||||
|
2020
Q3 | $690K | Hold |
|
|||||
|
2020
Q2 | $814K | Hold |
|
|||||
|
2020
Q1 | $513K | Hold |
|
|||||
|
2019
Q4 | $769K | Hold |
|
|||||
|
2019
Q3 | $712K | Hold |
|
|||||
|
2019
Q2 | $821K | Hold |
|
|||||
|
2019
Q1 | $889K | Hold |
|
|||||
|
2018
Q4 | $986K | Buy |
|